Trade

Cian Healthcare share price

Balanced risk
  • 30%Low risk
  • 30%Moderate risk
  • 30%Balanced risk
  • 30%High risk
  • 30%Extreme risk
  • 5.51(-1.96%)
    December 5, 2025 11:55:07 AM IST
    • NSE
    • BSE
  • Vol : 4.00 K (NSE + BSE)
    Last 20 day avg : 117.30 K

Cian Healthcare is trading -1.96% lower at Rs 5.51 as compared to its last closing price. Cian Healthcare has been trading in the price range of 5.51 & 5.51. Cian Healthcare has given 45.22% in this year & -5.55% in the last 5 days. The company posted a net profit of -7.73 Crores in its last quarter.Listed peers of Cian Healthcare include Torrent Pharmaceuticals (-0.74%), Divi's Laboratories (-0.04%), Sun Pharmaceutical Industries (-0.75%).The Mutual Fund holding in Cian Healthcare was at -% in . The MF holding has - from the last quarter. The FII holding in Cian Healthcare was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 06, 2025, 02:48 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -0.46
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    1.70
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.43
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
5.51
Highest
5.51
52 week range
Lowest
2.97
Highest
7.66
Cian Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
3,773.70-0.741,27,661.9766.6416.920.8417.62
Divi's Laboratories
Bullish
6,468.25-0.041,73,113.6278.2711.470.460.01
Sun Pharmaceutical Industries
Bullish
1,805.00-0.754,33,140.8537.946.040.880.50
Dr Reddy's Laboratories
Bullish
1,276.55-0.041,06,330.4218.803.170.632.34
Cipla
Neutral
1,520.55-0.041,22,825.6523.333.940.850.81
Cian Healthcare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2024-07-12Preferential issue of shares
2024-07-09Preferential issue of shares
2024-06-14Others
2024-06-05Others
2024-05-30Audited Results
About the company Cian Healthcare
  • IndustryBiotechnology & Drugs
  • ISININE05BN01019
  • BSE Code542678
  • NSE Code
Cian Healthcare Limited is an India-based company, which is engaged in manufacturing of Pharmaceuticals, OTCs, Supplements and Veterinary products. The Company is engaged in manufacturing multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets. Its portfolio comprises gynaecology, haematinic, cardio- diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrient products. It is also engaged in the business of manufacturing cosmetic products. The Company's services include pharma visual aid (book or spiral) design and printing, pharma literature design and printing, pharma monographs/ reference folders, LBL’s/ reminder cards design, pharma poster design, pharmaceutical carton/ catch cover designing, corporate identity design, advertising design, product information leaflet, and brand communication. The Company's subsidiary includes Dr. Smith Biotech Private Limited.
  • Management Info
  • Kalyani ChordiaChief Financial Officer
  • Bhushan KulkarniCompany Secretary and Compliance Officer
  • Suraj ZanwarManaging Director, Whole-Time Director
  • Santosh PimparkarAdditional Whole-Time Director
Cian Healthcare Share Price FAQs

Cian Healthcare is trading at 5.51 as on Fri Dec 05 2025 06:25:07. This is -1.96% lower as compared to its previous closing price of 5.62.

The market capitalization of Cian Healthcare is 13.77 Cr as on Fri Dec 05 2025 06:25:07.

The 52 wk high for Cian Healthcare is 7.66 whereas the 52 wk low is 2.97

Cian Healthcare can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: 32.51
  • Dividend Yield: 0.00%
  • D/E ratio: 1.70

Cian Healthcare reported a net profit of -25.98 Cr in 2025.